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Abstract
Background: Polychlorinated biphenyls (PCBs) are ubiquitous industrial chemicals that persist in
the environment and in human fatty tissue. PCBs are related to a class of compounds known as
dioxins, specifically 2,3,7,8-TCDD (tetrachloro-dibenzodioxin), which has been implicated as a
cause of altered sex ratio, especially in relation to paternal exposures.
Methods: In the 1960's, serum specimens were collected from pregnant women participating in
the Child Health and Development Study in the San Francisco Bay Area. The women were
interviewed and their serum samples stored at -20°C. For this study, samples were thawed and a
total of eleven PCBs were determined in 399 specimens. Secondary sex ratio, or sex ratio at birth,
was evaluated as a function of maternal serum concentrations using log-binomial and logistic
regression, controlling for hormonally active medications taken during pregnancy.
Results:  The relative risk of a male birth decreased by 33% comparing women at the 90th
percentile of total PCBs with women at the 10th percentile (RR = 0.67; 95% CI, 0.48–0.94; p = 0.02),
or by approximately 7% for each 1 μg/L increase in total PCB concentration. Although some
congener-specific associations with sex ratio were only marginally statistically significant, all nine
PCB congeners with < 30% of samples below the LOQ showed the same direction of association,
an improbable finding under the null hypothesis.
Conclusion: Maternal exposure to PCBs may be detrimental to the success of male sperm or to
the survival of male embryos. Findings could be due to contaminants, metabolites or PCBs
themselves.
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Background
Polychlorinated biphenyls (PCBs) are a class of chemi-
cally stable compounds that were produced in the United
States from the 1920's until 1977, and in Europe begin-
ning in the 1940's or 1950's for several decades, and were
widely used in industrial and some consumer products.
Each individual PCB congener represents one configura-
tion of 209 that are possible, based on the number and
location of attached chlorine atoms. These compounds
bioaccumulate up the food chain, such that the greatest
human sources are meat, fish, and both animal and
human breast milk. Because of their high lipophilicity,
PCBs are not readily cleared from the body [1-3].
A number of organochlorines, their metabolites, and their
contaminants have been characterized as endocrine-dis-
rupting chemicals. PCBs are structurally similar to thyrox-
ine, which is critical to in utero development [2-4]. Animal
studies have demonstrated altered thyroid homeostasis
following PCB exposure, although human studies have
produced mixed results [5]. Additionally, PCB congeners,
their metabolites, or related compounds (e.g., 2,3,7,8-tet-
rachlorodibenzo-p-dioxin and dichloro-diphenyl-trichlo-
roethane (DDT)) have been shown to have estrogenic,
anti-estrogenic or anti-androgenic activity [6-9], and some
human studies have found reduced sperm motility among
PCB-exposed subjects [10-12].
Following the chemical explosion that resulted in dioxin
contamination of residential areas in Seveso, Italy, a defi-
cit in male births of couples with high exposures was
observed [13,14]. A similar finding was reported for the
offspring of over 2,000 adults exposed in 1979 to cooking
oil in Taiwan that was contaminated with a mix of PCBs,
polychlorinated dibenzo furans and polychlorinated
dibenzo dioxins [15]. Data from a similar accident in
Japan were not consistent with an alteration in sex ratio
[16], but this report included a relatively small number of
births. Few studies at lower environmental exposure levels
have reported on sex ratio, and most have not used direct
measurements of individual PCBs.
This paper examines sex ratio in births occurring between
1964 and 1967 in the San Francisco Bay Area in relation
to concentrations of serum polychlorinated biphenyls in
archived serum specimens that were collected during the
pregnancies. The participants were a subset of those
enrolled in the Child Health and Development Study
(CHDS), a cohort of about 20,000 pregnancies. Because
the CHDS was conducted during the 1960's, a time of
peak production and use of these compounds, body bur-
dens were higher than those found in recent general pop-
ulation studies in western countries [17,18], yet lower
than some current highly-exposed populations [19,20].
Methods
Study population
The CHDS was a prospective cohort study that enrolled
about 20,000 pregnant women either attending prenatal
clinics or giving birth at Kaiser Foundation Health Plan
Medical Centers in the San Francisco Bay Area during the
1960's [20-22]. The Kaiser Health Plan, a prepaid inte-
grated health care system, at that time had enrolled 90
percent of membership through employer or union
groups (G Friedman, Kaiser-Permanente, personal com-
munication,1996). The population served was thus
largely persons having stable employment, with wealthy
and very poor persons generally not well represented.
Otherwise, members represented a broad cross-section of
the San Francisco Bay Area population.
The 399 woman/child pairs in this study were selected
from 3,412 CHDS children born April 1964 through April
1967 who participated in an extensive examination at five
years of age, described previously [23,24]. To be eligible
for our study (Table 1), women had to have completed
the enrollment interview before delivery and donated a
second or third trimester blood specimen, for which a suf-
ficient volume of serum still remained. As the study was
designed to examine a range of birth and developmental
outcomes, exclusions were made for: 1) non-singleton
deliveries, 2) children with severe anomalies or who did
not complete two cognitive exams and a hearing screen-
ing; 3) mothers who were deaf, had rubella during preg-
nancy, were taking thyroid medication in the 60 days
prior to blood draw, or took iodine-containing medica-
tions during pregnancy or in the six months prior to con-
ception [25]; and 4) infants born at gestational ages that
were unknown, less than 35, or greater than 45 completed
weeks. Based on regularly updated contact information
provided by the CHDS investigators, we selected children
residing in eight counties in or surrounding the greater
San Francisco Bay Area. The study was approved by the
Human Subjects Review Board at the University of Cali-
fornia, Davis.
After these exclusions, there remained a group of 1,291
children. We sampled all children with low scores on at
least one of two cognitive tests (below 10th percentile on
either the Peabody Picture Vocabulary Test or an abbrevi-
ated Raven's Progressive Matrices), or who failed a hearing
screening, and a 17 percent random sample of all others,
to achieve the targeted sample size. The motivation for
this design was to enhance power for the hypotheses
related to neurocognitive and neurosensory deficits
(which were of relatively low prevalence) while not
adversely affecting efficiency for other hypotheses. Several
authors have published papers on "reusing" data from
case- control studies – designs that are, in essence, a spe-
cial case of stratified sampling [26,27]. At the analysisEnvironmental Health 2008, 7:37 http://www.ehjournal.net/content/7/1/37
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stage, we adjusted for this design by applying normalized
weights in all regression model fitting (detailed below).
Finally, if women had more than one eligible child, we
sampled no more than one child for each mother. Serum
PCB concentrations were determined for 399 women in
this final sample.
PCB measurement
Laboratory methods have been described previously
[17,28]. Briefly, serum specimens collected during preg-
nancy were aliquoted and stored at -20° Celsius at
National Institutes of Health (NIH) facilities. For determi-
nation of PCBs the protocol was as follows: Samples were
thawed and then homogenized; surrogate standards (e.g,
2,3,4,4'-tetrachorobiphenyl (PCB International Union of
Pure and Applied Chemistry (IUPAC) #66)), and
2,3,3',5,5',6-hexachlorobiphenyl (PCB #165) and glacial
acetic acid were added, and the solution was mixed. The
PCBs were extracted three times with 90 percent hexane/
10 percent dichloromethane, and the extract was passed
through a 0.5 percent deactivated florisil column. The
PCBs were eluted with 60 milliliters of hexane and then
60 milliliters of 50 percent hexane/50 percent dichlo-
romethane. After concentration by rotary evaporation, the
internal standard 2,2',3,4,4',5,6,6'-octachlorobiphenyl
(PCB #204) was added. Serum extracts were analyzed by
gas chromatography with electron capture detection
(Hewlett-Packard 6890 Series) in parallel using an RTX-
5MS and an RTX-1701 column. All samples were analyzed
between January 14, 1998 and September 22, 1999 in
batches of 10 to 20 samples. Concentrations were
adjusted for percent recovery for each sample. Specimens
analyzed on batch dates with extremely high or low varia-
bility were re-analyzed, and the two values averaged.
Before analyzing any samples from our subjects, noncriti-
cal samples from the same cohort (i.e. of women in CHDS
who were lost to follow-up) were analyzed to assess the
integrity of the stored serum specimens. Organochlorine
determinations demonstrated comparability with other
historical samples, and lipids were in reference ranges.
We included PCBs that: (a) were measured in mixtures
reported (as of the late 1990's) to have associations with
reproductive, developmental or endocrine alterations in
animals or humans; (b) did not co-elute with other com-
pounds on either of the two columns; and (c) were
present in sufficient concentration in these samples [28].
These included: PCB #101, #105, #110, #118, #137,
#138, #153, #156, #170, #180, and #187. Values below
the limit of quantitation (LOQ) were imputed as
described previously [17]. The total of PCBs was calcu-
lated as the sum of the nine congeners that had fewer than
30% below the LOQ (PCB IUPAC #105, #110, #118,
#137, #138, #153, #170, #180, and #187).
Outcome and other variables
Sex of the infant was collected at the time of birth and
noted in the CHDS database. Because of our design, only
data on pregnancies that resulted in a live birth were
included.
Potential covariates were selected from CHDS databases
which included data on sociodemographics and maternal
health and pregnancy. To adjust for the potential effects of
maternal sex hormone or corticosteroid use during the
periconception period, all prescriptions and associated
dates were extracted for women in this study. A complete
list of medications prescribed during the index period
between thirty days prior to and four months after con-
ception was reviewed using references pertinent for the
Table 1: Exclusions of CHDS children from a 5-Year examination subset for organochlorine study
Excluded
Step Reason for exclusion N % Cases remaining
1 Mother is an unmarried minor or no interview completed 587 17.2 2825
2 Blood was drawn prior to second trimester or after 3rd trimester 177 5.2 2648
3 Not a singleton birth 28 0.8 2620
4 Raven or Peabody cognitive test score missing 60 1.8 2560
5 Hearing tests were not done in both ears 146 4.3 2414
6 Confounding anomalies present 21 0.6 2393
7M o t h e r  i s  d e a f 2 0.1 2391
8 Congenital rubella* 46 1.3 2345
9 Mother took a drug containing iodine 86 2.5 2259
10 Thyroid drugs were taken within 60 d of blood draw 7 0.2 2252
11 Gestational age is less than 244 or greater than 351 days 99 2.9 2153
12 No current address is available 468 13.7 1685
13 Does not reside in 1 of 8 included counties 337 9.9 1348
14 Only one sibling in family can be included; other siblings dropped 57 1.7 1291
*Included any mention of rubella in the chart, whether or not a diagnosis was made.Environmental Health 2008, 7:37 http://www.ehjournal.net/content/7/1/37
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time period of the study [29-31]. Active ingredients in
medications from earlier years were checked against cur-
rent references [32,33]. Mothers were coded (yes/no)
according to whether they had been prescribed sex hor-
mones or corticosteroids. Other potential adjustment var-
iables for the multivariate analysis were specimen
characteristics. These were: batch-date of laboratory anal-
ysis and an indicator for sample storage history (some
specimens had been immediately shipped for storage at
an NIH facility while others had been stored locally and
later shipped).
Data analysis
Log-binomial and logistic regression analyses were con-
ducted to estimate the relative risk (RR) and odds ratio
(OR), respectively, of male birth as a function of maternal
PCB concentrations. Since the odds ratio is a poor approx-
imation of the relative risk when the outcome is common
[34], the relative risk of male birth was estimated using
log-binomial regression [35], and forms the basis of our
primary analysis. As a secondary analysis and for purposes
of comparison with previous research, we estimated the
odds of male birth in relation to maternal PCB concentra-
tions using logistic regression. All regression models were
adjusted for specimen characteristics and prescription for
sex hormones or corticosteroids. Some maternal factors
have been implicated with altered sex ratio such as mater-
nal age, parity, and race [36]. However, since inclusion of
these measures did not alter PCB coefficients by more
than 10 percent, they were not included in our final mul-
tivariate models. Separate models were fit for total PCBs
and for the 9 specific PCB congeners that had less than 30
percent of their values below the LOQ. In all regression
models, PCB concentration was modeled as a continuous
variable in micrograms per liter of serum (μg/L) (parts per
billion (ppb)). To provide a more interpretable measure
of the PCB "effect size," we calculated a risk ratio compar-
ing sex ratio at the 90th vs. 10th percentiles of PCBs by mul-
tiplying the per-unit PCB coefficient by the concentration
difference between the 90th and 10th percentiles. In addi-
tion, normalized weights were applied to adjust for our
stratified sampling procedure; these weights were
inversely proportional to the sampling fraction in each
stratum. When applied to the regression analysis, the
results are as if the sample of 399 children was drawn
completely at random from the subset of 1291 children.
Thus, any potential bias created by the stratified sampling
procedure is removed. As in standard survey research, this
procedure ensures that all parameter estimates are valid
with respect to the larger sample or population from
which the stratified sample has been selected, and elimi-
nates any bias introduced by use of a stratified sample. To
account for potentially greater homogeneity within sam-
pling strata, robust variance estimates were calculated for
both log-binomial and logistic regression models. All
analyses were conducted using the GENMOD procedure
in SAS (version 9.1; SAS Institute, Inc., Cary, North Caro-
lina).
Results
Sample characteristics
Table 2 compares the sociodemographic characteristics of
the original CHDS cohort, the 3,412 children who
appeared for the 5-year examination, the 1,291 eligible
after exclusions, and the final study sample of 399. As
compared with the original cohort, the mothers of those
examined at five years were of similar age, more highly
educated, and less likely to be white. Those eligible and
selected for our study differed from the original cohort on
the same factors, with a greater percentage of African-
Americans meeting our eligibility criteria. Female children
were slightly more prevalent among those participating in
the 5-year examination than in the original cohort, and
among those eligible after our exclusions; finally, more
females were included in our study because of poorer
average performance on the Raven's Progressive Matrices,
one of the cognitive tests for which children with low
scores were over-sampled. Our study sample included
53.4 percent females as compared with 48.8 percent of the
original cohort. As described above, normalized weights
were used to account for stratified sampling; since the
sampling altered the sex ratio, these weights also resulted
in correction for the differential selection by gender.
PCB concentrations
The mean, median, 10th and 90th percentile of total mater-
nal PCBs were: 5.4, 4.7, 3.1, and 8.7 μg/L (ppb) of serum,
respectively. PCB #153, the most abundant congener in
this study, had a median of 1.1 μg/L (10th percentile: 0.6
μg/L serum; 90th percentile: 1.9 μg/L serum). These PCB
concentrations are similar to levels reported by others for
the United States from the same time period [37], and
higher than most but not all populations under study
today [18].
PCB concentrations and secondary sex ratio
Log-binomial regression analyses, in which we adjusted
for specimen characteristics and hormonally active medi-
cations, revealed that total maternal PCB concentration
was associated with a reduction in male births (p = 0.02).
Specifically, the relative risk of a male birth decreased by
33 percent comparing women at the 90th percentile of
total PCBs with those at the 10th percentile of total PCBs
(RR = 0.67; 95% CI: 0.48, 0.94), or by approximately 7
percent for each 1 μg/L (1 ppb) increase in total PCBs
(Table 3). In log-binomial regression models for specific
PCB congeners, the predicted relative risk of a male birth
decreased with higher maternal PCB concentration in
each and every congener measured, though most conge-
ners were only marginally associated with male birth. TheEnvironmental Health 2008, 7:37 http://www.ehjournal.net/content/7/1/37
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results from logistic regression models were similar in
direction, showing, as expected, larger odds ratios than
the relative risks derived from the log-binomial regression
analyses.
Discussion
We observed a reduction in the ratio of male:female births
in relation to total maternal PCB concentrations in this
population. Inverse associations between all nine PCB
congeners and secondary sex ratio were also observed,
though not all of these were statistically significant at the
0.05 level. In models adjusted for hormonal medications
taken in the periconceptional and early pregnancy period,
higher concentrations of total PCBs were significantly
associated with male birth ratio (p = 0.02). As PCB blood
concentrations have been shown to remain very stable
Table 2: Sample characteristics, Child Health and Development Study, 1964–67
Final stratified
random sample 
(n = 399)
Cases meeting
study criteria
(n = 1291)
Cases followed
up at 5 years
(n = 3412)
CHDS study
population
(n = 20754)
Characteristics* N %† N % N % N %
Maternal age
< 20 28 7 68 5 230 7 1731 9
20–29 242 61 786 61 2099 62 12028 59
≥ 30 128 32 436 34 1068 31 6724 33
Parity
0 122 31 400 31 1077 32 6289 31
1–2 177 44 605 47 1572 47 9270 45
≥ 3 100 25 286 22 717 21 5031 24
Race/ethnicity
White 194 49 648 50 1970 58 1347 66
African-American 165 41 496 38 1041 31 4936 24
Hispanic 7 2 40 3 130 4 678 3
Asian 20 5 70 5 150 4 783 4
Multi-racial/other 13 3 37 3 108 3 597 3
Mother's education
Not High School graduate 76 19 208 16 500 17 3341 19
High School graduate 160 40 484 38 1118 37 6661 38
Some college 163 41 599 46 1378 46 7549 43
Father's education
Not High School graduate 74 19 211 20 496 17 2997 18
High School graduate 111 29 339 32 789 27 4607 28
Some college 122 32 431 41 979 34 4329 26
College grad/RN 76 20 286 27 643 22 4681 28
Sex of infant
Female 213 53.4 658 51.0 1722 50.5 9451 48.8
Male 186 46.6 633 49.0 1690 49.5 9927 51.2
*Data missing for some characteristics for some study participants.
†Percentages may not total 100% due to rounding.
Table 3: Adjusted relative risk (RR) and odds ratio (OR) for a male birth (n = 399)*
Log-binomial model Logistic model
PCB exposure RR 95% CI p-value OR 95% CI p-value
Total PCBs† 0.67 0.48, 0.94 0.02 0.45 0.26, 0.80 0.007
PCB 105 0.76 0.57, 1.01 0.06 0.58 0.37, 0.91 0.02
PCB 110 0.79 0.59, 1.06 0.11 0.66 0.41, 1.07 0.09
PCB 118 0.85 0.65, 1.12 0.25 0.72 0.45, 1.15 0.17
PCB 137 0.77 0.57, 1.04 0.09 0.63 0.39, 1.02 0.06
PCB 138 0.82 0.62, 1.09 0.17 0.68 0.42, 1.09 0.10
PCB 153 0.82 0.61, 1.11 0.20 0.68 0.40, 1.15 0.15
PCB 170 0.75 0.56, 1.00 0.05 0.57 0.36, 0.91 0.02
PCB 180 0.89 0.69, 1.14 0.35 0.80 0.51, 1.24 0.32
PCB 187 0.80 0.58, 1.09 0.16 0.67 0.38, 1.17 0.16
*Adjusted RR and OR for a male birth for a given increase in PCB concentration from the 10th to the 90th percentile: Child Health and Development Study, 1964–67. 
Estimates adjusted for specimen characteristics and an indicator of a prescription for sex steroids, oral contraceptives or corticosteroids.
†Sum of PCB #105, 110, 118, 137, 138, 153, 170, 180, 187.Environmental Health 2008, 7:37 http://www.ehjournal.net/content/7/1/37
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during pregnancy [37], these findings suggest that high
maternal PCB concentrations, at least for some congeners,
may either favor the fertilization by female sperm, or
result in greater male embryonic or fetal losses. Sex ratio
alterations or decreased survival of wildlife in association
with organochlorine exposures have been well docu-
mented [38-41], although not all studies have confirmed
such findings [42].
Only a handful of human studies of PCBs with sufficient
sample sizes have reported data on sex ratio. At environ-
mental exposures, several provide some suggestion of a
reduced proportion of males [43-46]. Weisskopf and col-
leagues [46] examined consumers of sport-fish caught in
the Great Lakes and observed a reduction in male births in
association with maternal but not paternal serum PCB
concentration. In contrast, another investigation found
increased male offspring in relation to paternal PCB expo-
sures, though this analysis may have over-adjusted for
multiple exposures correlated with paternal PCBs [47].
Reports from the Yucheng [48] and Yusho [16] accidents
showed no alteration in sex ratio, however, serious short-
comings in these studies should be noted. The Yucheng
group consisted of a select set of mothers who had regis-
tered with the health department as having been affected,
and who had at least one live child in 1985. Not all
affected subjects were registered, and some of the most
severely affected children may not have survived: since
either of these factors could have been related to the sex of
the child, the sex ratio of the survivors could be highly
confounded. Moreover, both the Yucheng and the Yusho
studies were small: a total of 137 births in the former and
only 67 in the latter. These sample sizes would not be ade-
quate to detect small variations in sex ratio. Analysis of a
more complete cohort from Yucheng, numbering 469
births with paternal data and 902 with maternal data
revealed reduced male:female sex ratio when fathers were
exposed at a young age [15], results similar to those previ-
ously reported for dioxin exposures from the Seveso acci-
dent. Analyses for maternal exposures also showed a
lower than expected proportion of males, but the findings
were not statistically significant. The difference in findings
using maternal vs. paternal exposure appeared to be due,
at least partly, to a higher percentage of male offspring
among unexposed fathers than among unexposed moth-
ers, or, than expected in the population. Since every child
has both a mother and a father, but fewer fathers were
tested, this raises the question of selection bias for chil-
dren whose fathers participated in the study.
In addition to studies of secondary sex ratio, research on
the proportion of Y-bearing spermatozoa in relation to
paternal PCBs have produced mixed results, i.e., both pos-
itive and negative associations [49,50]. This would suggest
that increased paternal PCB concentrations may also alter
secondary sex ratio, but other factors may modify this
effect. It is not clear from these studies – due to inadequate
sample size – whether changes in Y-bearing spermatozoa
resulted in more or fewer male births.
The possibility of bias deserves consideration. Selection
factors would have to be associated with sex ratio and
PCBs, jointly to have produced artifacts for the relation-
ship of these variables of primary interest. Since demo-
graphic variables are not generally associated with sex
ratio, they would not bias the results. The slight prepon-
derance of girls followed up at age 5 years (50.5%) as
compared to the original cohort (48.8% female), com-
bined with our deliberate oversampling of children with
low cognitive scores or hearing difficulties increased the
percentage of females to 53.4%, however, our sampling
weights accounted for these differences, comparable to
their standard use in survey sampling. It is possible that
because a small number of deaths occurred between birth
and five years of age, part of the shift in sex ratio might be
due to far higher deaths among boys with higher PCBs, or
among girls with lower PCBs. At these exposure levels,
however, which were far lower than occurred in the Yusho
or Yucheng incidents, it seems unlikely that PCBs would
have had a sufficiently strong association with child mor-
tality to produce the results observed and yet not be
related to fetal mortality. If PCBs were strongly associated
with unknown or gestational age below 35 weeks, some
selection bias could have occurred by our exclusion of
these births. However, the literature does not support an
association of preterm delivery with PCBs, nor did we find
any trend of higher PCBs with earlier gestational age
among births at weeks 35–45 [23]. In regard to other var-
iables, the sample was representative of the original
cohort. Thus, selection bias seems unlikely to be of suffi-
cient magnitude to explain the findings.
Validity of our data is supported by the confirmation of
known risk factors for other outcomes, such as maternal
smoking, short stature, and low body mass index in rela-
tion to intrauterine growth restriction [23]. High quality
PCB determinations were ensured by use of within-batch
replicates, standards across batches, and surrogate stand-
ards. Thus, in comparison with previous work, our study
is unique in that it thoroughly addresses maternal expo-
sures, uses an adequate sample, has high quality direct
measurements of PCB exposures close in time to the
events of interest, and represents exposures at the upper
end of today's environmentally exposed populations.
Conclusion
In this study, we observed a lower secondary male:female
ratio in association with increased maternal serum PCB
concentrations. If not due to an unidentified bias, these
results may indicate that with higher exposures to PCBsEnvironmental Health 2008, 7:37 http://www.ehjournal.net/content/7/1/37
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comes either greater susceptibility of male embryos or a
more favorable environment for X-chromatin-bearing
sperm. The association could be due to contaminants,
PCB metabolites, or the PCBs themselves.
Although PCB concentrations are slowly declining, stud-
ies in historical populations such as the CHDS provide an
upper limit on the magnitude of toxic effects expected
from today's environmental levels of these same com-
pounds in most parts of the world. Secondly, these inves-
tigations are useful for assessing reproductive
perturbations in populations currently exposed to higher
levels, e.g., those that rely on fish from contaminated
lakes and seas or reside near former manufacturing facili-
ties. Thirdly, if the findings are actually due to contami-
nants associated with PCB mixtures rather than PCBs
themselves, then attention should be paid to trends in the
contaminants, regardless of their source. Finally, other
chemical classes with similar structure, such as PBDEs
(polybrominated diphenyl ethers), are widely used in
plastic casings and foam products and share many of the
biochemical and toxicologic properties of PCBs [51,52].
As PBDE body burdens are rapidly increasing in wildlife
and human populations [53,54], studies like this one pro-
vide an indication of potential effects from these newer
compounds.
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